KL
Therapeutic Areas
Bicycle Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| BT5528 | Solid Tumors (EphA2) | Phase 1/2 |
| BT8009 | Solid Tumors (Nectin-4) | Phase 1/2 |
| BT7480 | Solid Tumors (Nectin-4 & CD137) | Phase 1 |
| BT1718 | Solid Tumors (MT1-MMP) | Phase 1/2a |
| BT7455 | Solid Tumors (EphA2 & CD137) | Preclinical |
| Bicycle Toxin Conjugates (BTCs) | Various Solid Tumors | Discovery/Preclinical |
| Bicycle Radio Conjugates (BRCs) | Various Solid Tumors | Discovery/Preclinical |
| Bicycle Immune Cell Agonists (BICAs) | Immuno-oncology | Discovery/Preclinical |